[Influence of an anticholinesterase substance, Nivalin, on the development of experimental arteriosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism*; D002791:Cholesterol, Dietary; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D004036:Diet, Atherogenic; D004195:Disease Models, Animal; D005702:Galantamine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D008954:Models, Biological; D011817:Rabbits
D002791:Cholesterol, Dietary; D002800:Cholinesterase Inhibitors; D005702:Galantamine
Etude de l'influence de la substance anticholinestérasique-Nivaline-sur le développement de l'athérosclérose expérimentale.